biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > so this new deal brings no volume or price movement

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Apr 15, 2022 6:24pm

204 Views

Post# 34606991

RE:RE:RE:RE:RE:RE:RE:so this new deal brings no volume or price movement

Frt said, "I know enough not to have wasted years invested in this stock...unlike many of you who have lost a lot of money."

Yeah, well, you're still here looking for a place to slot yourself in to make a buck. I say stick around. You can probably do just that.

Classy of you though, to throw that comment into people's faces.

jd

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!